Safety and Immunogenicity of a Hexavalent Vaccine Administered at 2, 4 and 6 Months of Age With or Without a Heptavalent Pneumococcal Conjugate Vaccine-Reference-Cited by-同舟云学术

Safety and Immunogenicity of a Hexavalent Vaccine Administered at 2, 4 and 6 Months of Age With or Without a Heptavalent Pneumococcal Conjugate Vaccine

Published:2013-01 Issue:1 Volume:32 Page:54-61
ISSN:0891-3668
Container-title:Pediatric Infectious Disease Journal
language:en
Short-container-title:

Author:

Tapiéro Bruce,Halperin Scott A.,Dionne Mark,Meekison William,Diaz-Mitoma Francisco,Zickler Paul,Rubin Earl,Embree Joanne,Bhuyan Prakash,Lee Andrew W.,Li Minran,Tomovici Antigona

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Microbiology (medical),Pediatrics, Perinatology and Child Health

Reference31 articles.

1. Physician and parent opinions.;Woodin;Are children becoming pincushions from immunizations Arch Pediatr Adolesc Med,1995

2. Barriers to measles and pertussis immunization: the knowledge and attitudes of Pennsylvania primary care physicians.;Zimmerman;Am J Prev Med,1997

3. Physician concerns about vaccine adverse effects and potential litigation.;Zimmerman;Arch Pediatr Adolesc Med,1998

4. Societal impact of combination vaccines: experiences of physicians, nurses, and parents.;Koslap-Petraco;J Pediatr Health Care,2008

5. Communicating the benefits of combination vaccines to parents and health care providers.;Koslap-Petraco;J Pediatr Health Care,2003

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combination Vaccines;Plotkin's Vaccines;2023

2. Safety evaluation of the DTaP5-IPV-Hib-HepB vaccine: a review;Expert Opinion on Drug Safety;2021-11-27

3. Safety of vaccines used for routine immunization in the United States: An updated systematic review and meta-analysis;Vaccine;2021-06

4. Protective immune responses against Haemophilus influenza type b elicited by a fully-liquid DTaP-IPV-Hib-HepB vaccine (VAXELIS™);Vaccine;2021-03

5. Safety and immunogenicity of a fully-liquid DTaP-IPV-Hib-HepB vaccine (Vaxelis™) in premature infants;Human Vaccines & Immunotherapeutics;2020-08-04